Francois Binet

Senior Principal Scientist at SemaThera Inc - Westmount, QC, CA

Francois Binet's Colleagues at SemaThera Inc
Garth Cumberlidge

President, Director & Chief Executive Officer

Contact Garth Cumberlidge

Francois Binet's Contact Details
HQ
N/A
Location
Company
SemaThera Inc
Francois Binet's Company Details
SemaThera Inc logo, SemaThera Inc contact details

SemaThera Inc

Westmount, QC, CA • 5 - 9 Employees
BioTech/Drugs

SemaThera is a spin-off company from AmorChem Fund 1, which focuses on a novel target, semaphorin 3A (SEMA3A). The Company is currently developing bispecific SEMA3A / VEGF inhibitors (traps) to prevent vascular leakage and damper the inflammation in diabetic macular edema (DME). The technology targets the 30% DME patients who are poor responders to current anti-VEGF therapies.

diabetic macular edema ocular diseases semaphorin 3A
Details about SemaThera Inc
Frequently Asked Questions about Francois Binet
Francois Binet currently works for SemaThera Inc.
Francois Binet's role at SemaThera Inc is Senior Principal Scientist.
Francois Binet's email address is ***@semathera.com. To view Francois Binet's full email address, please signup to ConnectPlex.
Francois Binet works in the Biotechnology industry.
Francois Binet's colleagues at SemaThera Inc are Véronique Bougie, Normand Beaulieu, Garth Cumberlidge, Michelle Barbagallo and others.
Francois Binet's phone number is N/A
See more information about Francois Binet